Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence
Wang Y, Daar E, Huang Y, Xiong D, Shen J, Zhou L, Siqueiros L, Guerrero M, Rosen M, Liu H. Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence. AIDS And Behavior 2023, 27: 4041-4051. PMID: 37401993, PMCID: PMC10598162, DOI: 10.1007/s10461-023-04118-9.Peer-Reviewed Original ResearchConceptsLog viral loadViral loadClinical trialsHIV RNA viral loadUsual care groupHIV viral suppressionRNA viral loadRandomized clinical trialsSelf-reported adherenceLongitudinal mixed effects modelsViral suppressionClinical outcomesCare groupWeek 28Week 16Intervention groupAntiretroviralsIntervention effectsVulnerable populationsAdherenceMixed effects modelsRandom interceptRetention rateCOVID-19 pandemicIngestible sensor